MUC1 and breast cancer: In conclusion, this study highlighted the TA-MUC1 epitope as detected by PankoMab-GEXTM to be widely expressed in a large body of breast cancer tissue samples, and - in case of its membrane-restricted expression - to be an independent predictor for better survival.